Q32 Bio Inc. SEC filings QTTB
Q32 Bio Inc. has 588 filings in SEC EDGAR's recent list, going back to Jan 6, 2016. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 30, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 14, 2026 | Sep 14, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| EFFECT | Filing | Jul 28, 2026 | — |
| 424B3 | Prospectus | Jul 28, 2026 | — |
| S-3 | Shelf registration | Jul 17, 2026 | — |
| 8-K |
Current report
Material agreement
|
Jul 15, 2026 | Jul 14, 2026 |
| 424B5 | Prospectus supplement | Jul 15, 2026 | — |
| EFFECT | Filing | Jul 13, 2026 | — |
| 424B5 | Prospectus supplement | Jul 13, 2026 | — |
| 8-K |
Current report
Other events
|
Jul 13, 2026 | Jul 13, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 13, 2026 | Jul 13, 2026 |
| S-3 | Shelf registration | Jun 25, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2026 | Jun 12, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
May 27, 2026 | May 26, 2026 |
| 10-Q | Quarterly report | May 5, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 5, 2026 | May 5, 2026 |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Jun 12, 2026 |
| 8-K |
Current report
Other events
|
Apr 24, 2026 | Apr 24, 2026 |
| 424B5 | Prospectus supplement | Apr 24, 2026 | — |
| 8-K |
Current report
Material agreement
|
Mar 27, 2026 | Mar 27, 2026 |
| 424B5 | Prospectus supplement | Mar 27, 2026 | — |
| S-8 | Employee stock plan registration | Mar 10, 2026 | — |
| 10-K | Annual report | Mar 10, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2026 | Mar 10, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 17, 2026 | Feb 17, 2026 |
| 424B5 | Prospectus supplement | Feb 17, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Dec 19, 2025 | Dec 17, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended, Acquisition or sale of assets, Regulation FD disclosure, Other events
|
Dec 1, 2025 | Nov 28, 2025 |
| 10-Q | Quarterly report | Nov 13, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2025 | Nov 13, 2025 |
| 8-K |
Current report
Other events
|
Oct 21, 2025 | Oct 21, 2025 |
| UPLOAD | Letter from the SEC | Aug 28, 2025 | — |
| CORRESP | Letter to the SEC | Aug 26, 2025 | — |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2025 | Aug 6, 2025 |
| CORRESP | Letter to the SEC | Jul 31, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 30, 2025 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 25, 2025 | Jun 20, 2025 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
Jun 17, 2025 | Jun 13, 2025 |
| 8-K |
Current report
Listing notice
|
May 23, 2025 | May 19, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 13, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 25, 2025 | Apr 25, 2025 |
| EFFECT | Filing | Apr 21, 2025 | — |
| CORRESP | Letter to the SEC | Apr 17, 2025 | — |
| EFFECT | Filing | Apr 16, 2025 | — |
| UPLOAD | Letter from the SEC | Apr 16, 2025 | — |
| POS AM | Filing | Apr 11, 2025 | — |
| S-3 | Shelf registration | Apr 11, 2025 | — |
| PRE 14A | Preliminary proxy statement | Apr 11, 2025 | Jun 13, 2025 |
| S-8 | Employee stock plan registration | Mar 11, 2025 | — |
| 424B3 | Prospectus | Mar 11, 2025 | — |
| 10-K | Annual report | Mar 11, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2025 | Mar 11, 2025 |
| 424B3 | Prospectus | Mar 10, 2025 | — |
| 8-K |
Current report
Other events
|
Mar 10, 2025 | Mar 8, 2025 |
| 424B3 | Prospectus | Feb 10, 2025 | — |
| 8-K |
Current report
Exit or restructuring costs, Regulation FD disclosure
|
Feb 10, 2025 | Feb 10, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 424B3 | Prospectus | Dec 11, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 11, 2024 | Dec 10, 2024 |
| 424B3 | Prospectus | Nov 7, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 424B3 | Prospectus | Aug 8, 2024 | — |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 424B3 | Prospectus | Jul 9, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 9, 2024 | Jul 9, 2024 |
| S-8 | Employee stock plan registration | May 31, 2024 | — |
| 424B3 | Prospectus | May 9, 2024 | — |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| EFFECT | Filing | Apr 29, 2024 | — |
| 424B3 | Prospectus | Apr 29, 2024 | — |
| CORRESP | Letter to the SEC | Apr 25, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 25, 2024 | — |
| S-1 | Registration statement | Apr 19, 2024 | — |
| 10-K/A | Amended annual report | Apr 12, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Results of operations, New debt, Unregistered share sale, Change to shareholder rights, Auditor change, Change in control, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Mar 27, 2024 | Mar 25, 2024 |
| 8-K/A |
Amended current report
Other events
|
Mar 22, 2024 | Mar 20, 2024 |
| 8-K |
Current report
Other events
|
Mar 20, 2024 | Mar 20, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Mar 15, 2024 | Mar 15, 2024 |
| POS EX | Filing | Mar 13, 2024 | — |
| 424B3 | Prospectus | Mar 13, 2024 | — |
| 10-K | Annual report | Mar 13, 2024 | Dec 31, 2023 |
| 425 | Filing | Mar 11, 2024 | — |
| 8-K |
Current report
Other events
|
Mar 11, 2024 | Mar 11, 2024 |
| 425 | Filing | Feb 21, 2024 | — |
| SEC STAFF LETTER | Filing | Feb 14, 2024 | — |
| EFFECT | Filing | Feb 14, 2024 | — |
| 424B3 | Prospectus | Feb 14, 2024 | — |
| CORRESP | Letter to the SEC | Feb 13, 2024 | — |
| S-4/A | Filing | Feb 13, 2024 | — |
| CORRESP | Letter to the SEC | Feb 12, 2024 | — |
| S-4/A | Filing | Feb 12, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 9, 2024 | — |
| S-4/A | Filing | Jan 29, 2024 | — |
| CORRESP | Letter to the SEC | Jan 26, 2024 | — |
| 425 | Filing | Jan 26, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 26, 2024 | Jan 26, 2024 |
| SEC STAFF LETTER | Filing | Jan 23, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 22, 2024 | — |
| 425 | Filing | Jan 3, 2024 | — |
| 8-K |
Current report
Listing notice, Regulation FD disclosure
|
Jan 3, 2024 | Dec 29, 2023 |
| S-4 | Registration for a merger or exchange | Dec 18, 2023 | — |
| 425 | Filing | Nov 16, 2023 | — |
| 425 | Filing | Nov 16, 2023 | — |
| 425 | Filing | Nov 16, 2023 | — |
| 425 | Filing | Nov 16, 2023 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Change in control, Officer or director change
|
Nov 16, 2023 | Nov 16, 2023 |
| 425 | Filing | Nov 16, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 16, 2023 | Nov 16, 2023 |
| 10-Q | Quarterly report | Nov 14, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 10, 2023 | Oct 10, 2023 |
| 10-Q | Quarterly report | Aug 14, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Exit or restructuring costs, Other events
|
Jul 27, 2023 | Jul 25, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2023 | Jun 14, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 14, 2023 |
| EFFECT | Filing | Mar 17, 2023 | — |
| CORRESP | Letter to the SEC | Mar 16, 2023 | — |
| UPLOAD | Letter from the SEC | Mar 14, 2023 | — |
| S-3 | Shelf registration | Mar 9, 2023 | — |
| S-8 | Employee stock plan registration | Mar 9, 2023 | — |
| 10-K | Annual report | Mar 9, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 4, 2023 | Jan 4, 2023 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Officer or director change
|
Sep 8, 2022 | Sep 6, 2022 |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2022 | Jun 15, 2022 |
| 8-K |
Current report
Other events
|
Jun 13, 2022 | Jun 13, 2022 |
| 10-Q | Quarterly report | May 16, 2022 | Mar 31, 2022 |
| DEFA14A | Additional proxy material | Apr 29, 2022 | — |
| DEF 14A | Proxy statement | Apr 29, 2022 | Jun 15, 2022 |
| 8-K |
Current report
Officer or director change
|
Apr 21, 2022 | Apr 19, 2022 |
| 10-K | Annual report | Mar 23, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets
|
Mar 16, 2022 | Mar 10, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 18, 2022 | Feb 16, 2022 |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
Feb 3, 2022 | Jan 28, 2022 |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2021 | Jun 17, 2021 |
| 10-Q | Quarterly report | May 6, 2021 | Mar 31, 2021 |
| DEFA14A | Additional proxy material | Apr 29, 2021 | — |
| DEF 14A | Proxy statement | Apr 29, 2021 | Jun 17, 2021 |
| SEC STAFF LETTER | Filing | Apr 19, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Apr 12, 2021 | Apr 7, 2021 |
| 8-K |
Current report
Other events
|
Apr 9, 2021 | Apr 6, 2021 |
| 424B5 | Prospectus supplement | Apr 8, 2021 | — |
| 424B5 | Prospectus supplement | Apr 7, 2021 | — |
| SEC STAFF LETTER | Filing | Mar 22, 2021 | — |
| EFFECT | Filing | Mar 12, 2021 | — |
| POS AM | Filing | Mar 11, 2021 | — |
| 10-K | Annual report | Mar 11, 2021 | Dec 31, 2020 |
| POSASR | Filing | Mar 11, 2021 | — |
| 8-K |
Current report
Agreement ended
|
Mar 1, 2021 | Feb 26, 2021 |
| 8-K |
Current report
Other events
|
Feb 8, 2021 | Feb 8, 2021 |
| CT ORDER | Filing | Feb 3, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 6, 2021 | Jan 6, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 18, 2020 | Dec 16, 2020 |
| 10-Q | Quarterly report | Nov 9, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale
|
Nov 9, 2020 | Nov 9, 2020 |
| 10-Q | Quarterly report | Aug 10, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Officer or director change
|
Jul 21, 2020 | Jul 21, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2020 | Jun 10, 2020 |
| 10-Q | Quarterly report | May 7, 2020 | Mar 31, 2020 |
| DEFA14A | Additional proxy material | Apr 28, 2020 | — |
| DEF 14A | Proxy statement | Apr 28, 2020 | Jun 10, 2020 |
| S-3ASR | Automatic shelf registration | Mar 12, 2020 | — |
| 10-K | Annual report | Mar 12, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Other events
|
Dec 19, 2019 | Dec 17, 2019 |
| 10-Q | Quarterly report | Nov 12, 2019 | Sep 30, 2019 |
| 10-Q | Quarterly report | Aug 8, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jul 15, 2019 | Jul 9, 2019 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 27, 2019 | Jun 24, 2019 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2019 | Jun 6, 2019 |
| 10-Q | Quarterly report | May 13, 2019 | Mar 31, 2019 |
| DEFA14A | Additional proxy material | Apr 25, 2019 | — |
| DEF 14A | Proxy statement | Apr 25, 2019 | Jun 6, 2019 |
| 8-K |
Current report
Other events
|
Apr 11, 2019 | Apr 9, 2019 |
| 424B5 | Prospectus supplement | Apr 10, 2019 | — |
| EFFECT | Filing | Apr 9, 2019 | — |
| UPLOAD | Letter from the SEC | Apr 8, 2019 | — |
| 424B5 | Prospectus supplement | Apr 8, 2019 | — |
| 8-K |
Current report
Results of operations, Other events
|
Apr 8, 2019 | Apr 4, 2019 |
| CORRESP | Letter to the SEC | Apr 8, 2019 | — |
| 8-K |
Current report
Material agreement
|
Apr 1, 2019 | Apr 1, 2019 |
| S-3 | Shelf registration | Apr 1, 2019 | — |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- QTTB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Waltham, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1661998
- Former names
- Q32 Bio Inc. (until Nov 4, 2026); Homology Medicines, Inc. (until Mar 22, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.